VF
COGT icon

Virtu Financial’s Cogent Biosciences COGT Stock Holding History

Virtu Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,446
Closed -$671K – 1700
2026
Q1 		$671K Sell
17,446
-20,173
-54% -$745K 0.03% 471
2025
Q4 		$1.34M Buy
+37,619
New +$1.06M 0.05% 253
2024
Q4 		– Sell
-13,610
Closed -$147K – 1617
2024
Q3 		$147K Buy
+13,610
New +$133K 0.01% 857
2024
Q1 		– Sell
-13,598
Closed -$80K – 1505
2023
Q4 		$80K Buy
13,598
+1,293
+11% +$9.91K 0.01% 1074
2023
Q3 		$120K Buy
+12,305
New +$146K 0.01% 790
2022
Q3 		– Sell
-30,063
Closed -$271K – 1794
2022
Q2 		$271K Buy
+30,063
New +$205K 0.02% 625

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtu Financial's COGT Position: Q2 2026 in Review

Virtu Financial sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 17,446 shares — an estimated $671K sold.

Virtu Financial first reported a position in COGT in Q2 2022 and held it in 6 quarters. The position peaked at $1.34M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Virtu Financial reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 17,446 Cogent Biosciences shares in Q2 2026, an estimated $671K.
  • Virtu Financial first reported a position in Cogent Biosciences in Q2 2022 and held it in 6 quarters.
  • Virtu Financial's Cogent Biosciences position peaked at $1.34M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.